Senior Business Analyst
Lars Gredsted is a Board Member of Acesion Pharma representing the Wellcome Trust. Lars is a Senior Business Analyst and joined the Wellcome Trust in 2010. He previously worked with in-licensing of early stage research projects at Union Life Sciences in Oxford. Lars has also worked as management consultant with the Boston Consulting Group, where he worked with marketing strategies for companies in the life science and industrial biotech areas. Lars gained his PhD from the European Molecular Biology Laboratory (EMBL)/Heidelberg University and subsequently worked as a postdoc at EMBL in Heidelberg and at the Biotech Research and Innovation Center (BRIC) in Copenhagen. In addition to his PhD, Lars holds an MPhil in Bioscience Enterprise from Cambridge University and a Master of Biochemistry from the University of Copenhagen.